1. |
White AR, Rampes H, Liu JP, et al. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev, 2014, (1): CD000009.
|
2. |
思金华, 赵晨, 刘妮波, 等. 基于SCIE和GoPubMed的针灸学文献统计分析. 中国针灸, 2015, 35(12): 1309-1314.
|
3. |
王锐卿, 吕九亨, 贾春生. 海外针灸对国内针灸的启示与思考. 中国针灸, 2020, 40(10): 1123-1127.
|
4. |
Ma Y, Dong M, Zhou K, et al. Publication trends in acupuncture research: a 20-year bibliometric analysis based on PubMed. PLoS One, 2016, 11(12): e0168123.
|
5. |
Long Y, Wang X, Xiao W, et al. Use and reporting of risk of bias tools in 825 systematic reviews of acupuncture: a cross-sectional study. Acupunct Med, 2021, 39(4): 318-326.
|
6. |
Marshall IJ, Marshall R, Wallace BC, et al. Rapid reviews may produce different results to systematic reviews: a meta-epidemiological study. J Clin Epidemiol, 2019, 109: 30-41.
|
7. |
Fox DM. Evidence and health policy: using and regulating systematic reviews. Am J Public Health, 2017, 107(1): 88-92.
|
8. |
Whiting P, Savović J, Higgins JP, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol, 2016, 69: 225-234.
|
9. |
丁泓帆, 吴琼芳, 杨楠, 等. 评估系统评价偏倚风险的ROBISIS工具实例解读. 中国循证医学杂志, 2016, 16(1): 115-121.
|
10. |
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, 372: n71.
|
11. |
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 2009, 339: b2535.
|
12. |
高亚, 刘明, 杨珂璐, 等. 系统评价报告规范: PRISMA2020与PRISMA 2009的对比分析与实例解读. 中国循证医学杂志, 2021, 21(5): 606-616.
|
13. |
徐蕴, 李尚, 汤大朋, 等. 中国科学引文数据库针灸期刊发表的Meta分析文献质量评价. 中国针灸, 2019, 39(11): 1247-1253.
|
14. |
Liu Y, Zhang R, Huang J, et al. Reporting quality of systematic reviews/meta-analyses of acupuncture. PLoS One, 2014, 9(11): e113172.
|
15. |
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 2009, 339: b2700.
|
16. |
Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 2021, 372: n160.
|
17. |
Vu-Ngoc H, Elawady SS, Mehyar GM, et al. Quality of flow diagram in systematic review and/or meta-analysis. PLoS One, 2018, 13(6): e0195955.
|
18. |
Zabor EC, Reddy CA, Tendulkar RD, et al. Logistic regression in clinical studies. Int J Radiat Oncol Biol Phys, 2021, S0360-3016(21): 02646-8.
|
19. |
Hind D, Booth A. Do health technology assessments comply with QUOROM diagram guidance. An empirical study. BMC Med Res Methodol, 2007, 7: 49.
|
20. |
Ma B, Qi GQ, Lin XT, et al. Epidemiology, quality, and reporting characteristics of systematic reviews of acupuncture interventions published in Chinese journals. J Altern Complement Med, 2012, 18(9): 813-817.
|
21. |
Sun X, Zhou X, Yu Y, et al. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer's disease before and after PRISMA introduction. BMC Med Res Methodol, 2018, 18(1): 154.
|
22. |
Liu H, Zhou X, Yu G, et al. The effects of the PRISMA statement to improve the conduct and reporting of systematic reviews and meta-analyses of nursing interventions for patients with heart failure. Int J Nurs Pract, 2019, 25(3): e12729.
|
23. |
Hardt JL, Metzendorf MI, Meerpohl JJ. Surgical trials and trial registers: a cross-sectional study of randomized controlled trials published in journals requiring trial registration in the author instructions. Trials, 2013, 14: 407.
|
24. |
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.1. 0, 2020. Available at:http://handbook-5-1.cochrane.org/.
|
25. |
Lam MT, McDiarmid M. Increasing number of databases searched in systematic reviews and meta-analyses between 1994 and 2014. J Med Libr Assoc, 2016, 104(4): 284-289.
|
26. |
李青, 夏芸, 牟钰洁, 等. 国内中文期刊发表的中医药系统综述和Meta分析文献质量再评价. 北京中医药大学学报(中医临床版), 2012, 19(3): 28-33.
|